GENE ONLINE|News &
Opinion
Blog

M&A
M&A Cardiovascular Disease
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
M&A Amyloidosis
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
M&A Gene Therapy
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
M&A Molecular Diagnostics
Roche to Acquire Long-Time Partner to Advance Molecular Diagnostics for Infectious Diseases
2021-09-10
IPO SPAC
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
M&A Immuno-oncology
Pfizer Jumps into the CD47 Race With $2.3B Buyout of Trillium
2021-08-24
M&A Federal Trade Commission
Illumina Completes GRAIL Acquisition Without Approval From FTC
2021-08-19
M&A CRO
Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition
2021-08-17
Deals
Harmony Acquires New Asset for $3.5 Million to Treat Rare Neurological Diseases
2021-08-11
M&A Chemoproteomics
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
M&A DNA Sequencing
PacBio Bolsters its Long-Read Sequencing Workflow, Makes Second Acquisition in Two Weeks
2021-08-03
Deals
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-02Partner
Manufacturing
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
M&A Antibody Therapy
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Deals
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
1 … 6 7 8 9 10 … 14
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top